FindTrial
Sign In

Hepatic changes after cholecystectomy for gall stone disease by using transverse ultrasonography

Effect of Cholecystectomy for symptomatic gall stone disease on hepatic steatosis using Transabdominal ultrasonography

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/03/050234
Enrollment
103
Registered
2023-03-02
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R101- Pain localized to upper abdomen Health Condition 2: R101- Pain localized to upper abdomen

Interventions

None listed

Sponsors

Government Medical College and Hospital, sector 32, Chandigarh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Male or Female > 18 years

Exclusion criteria

Exclusion criteria: 1. Cholecystectomy for malignant disease 2. Patients with history of alcohol consumption 3. Haemochromatosis 4. Wilsonâ??s disease 5. Autoimmune hepatitis 6. Primary biliary cirrhosis 7. Sclerosing cholangitis 8. Biliary obstruction 9. Alpha-1 antitrypsin deficiency 10. Ischaemic cardiac or cerebrovascular disease 11. Use of oestrogens, amiodarone, steroids, tamoxifen or lipid lowering agents 12. Viral hepatitis (positive serum hepatitis B surface antigen or positive serum hepatitis C â??antibody) 13. Pregnancy 14. Patients with history of bowel resection 15. Diabetes mellitus 16. BMI > 30

Design outcomes

Primary

MeasureTime frame
Hepatic steatosisTimepoint: after 3 months of surgery—

Secondary

MeasureTime frame
Lipid profile, apoB, Liver function testTimepoint: After 3 months of surgery—

Countries

India

Contacts

Public ContactUMANG DHAKARIA

Government medical college and hospital sector 32 Chandigarh

rajbansiwal_72@yahoo.co.in9646121566

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026